|
| |
| | | 44374 | | 18.01.1982 | | GlaxoSmithKline AG | | 03.07.2006 | | | | | 02.07.2021 | | | | | | 04.01.10. | | 04.10.2019 | | 04.01.10. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Zantic | Injektionslösung | Injection solution (Ranitidine 50mg / 5ml) | A02BA02 | CI | | 02 | Zantic | | (Ranitidine 50 mg) | | |
|
|
|
